MiBo ThermoFlo Lid Temperature Evaluation

Exclusion Criteria

• •Potential subjects who meet any of the following criteria will be excluded from participating in the study:
• •1. Currently pregnant or breastfeeding.
• •2. Any systemic disease (e.g., Sjögren's Syndrome), allergies, infectious disease (e.g., hepatitis, tuberculosis), contagious immunosuppressive diseases (e.g., HIV), autoimmune disease (e.g. rheumatoid arthritis), or other diseases, by self-report, which are known to interfere with participation in the study.
• •3. Clinically significant (Grade 3 or 4 on the FDA classification scale) slit lamp findings (e.g. corneal edema, neovascularization or staining, tarsal abnormalities or bulbar injection).
• •4. Grade 3-4 Percentage of Partial Meibomian Glands on the Pult 5-point grading scale.
• •5. Any active Ocular Infection or Inflammation
• •6. Any history of eyelid surgery or abnormality
• •7. History of Metal Implants in the Eyelids
• •8. Any known hypersensitivity or allergic reaction to ultrasound coupling gel.
• •9. LASIK Surgery within 2 weeks of the Baseline Visit.
• •10. Participation in any contact lens or lens care product clinical trial within 14 days prior to study enrollment.
• •11. History of MiBo ThermoFlo or Lipiflow treatment Within the Last 6 months.
• •12. Employee or immediate family member of an employee of clinical site (e.g., Investigator, Coordinator, Technician).